LifeMD (LFMD) experienced a significant 30.07% decrease in after-hours trading on Tuesday, reaching $8.28.
This drop was driven by the company’s Q2 financial results, which revealed a revenue miss of $62.2 million and a higher than expected loss per share of $0.06. Despite a 23% year over year revenue growth, investors reacted negatively to the earnings report, leading to the sharp decline in LFMD’s stock price.